Abstract
Introduction. The risk of venous thromboembolism (VTE) associated with malignancy is 4.1-fold greater than patients without malignancy. Malignancypatientst has a greater risk of bleeding with the commonly used anticoagulant therapy. Inferior Vena Cava Filter (Ihas have been recommended as a controversial alternative. This study aims to find the most robust evidence of the safety, advantage, and clinical outcome of the IVCF for managing VTE associated with malignancy.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call